Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars

Area of Science:

• Biomaterials Science
• Dermatology
• Regenerative Medicine

Background:

• Pathological scars result from abnormal wound healing, causing disfigurement and dysfunction.
• Current treatments like surgery and corticosteroids have limited efficacy, high recurrence, and side effects.
• Scar tissue's dense extracellular matrix impedes drug penetration, reducing therapeutic effectiveness.

Purpose of the Study:

• To systematically review the pathogenesis and molecular mechanisms of pathological scars.
• To summarize current and emerging treatments for pathological scars.
• To highlight novel biomaterial-based drug delivery systems for scar management.

Main Methods:

• Literature review of pathological scar pathogenesis and treatments.
• Analysis of molecular mechanisms underlying scar formation.
• Evaluation of biomaterial-based drug delivery systems and transdermal technologies.

Main Results:

• Pathological scars involve aberrant extracellular matrix deposition and fibrotic processes.
• Existing treatments show significant limitations in efficacy and tolerability.
• Biomaterial-based systems offer sustained drug release and improved penetration for scar treatment.

Conclusions:

• Biomaterial-based drug delivery systems represent a promising strategy for overcoming limitations in pathological scar treatment.
• Further research into novel biomaterials and transdermal technologies is crucial for advancing scar management.
• These innovative approaches hold potential for improving patient quality of life by addressing disfigurement and dysfunction.